This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Biogen, Inc.

Drug Names(s): HMN-214

Description: HMN-214 is a pro-drug of stilbene, an aromatic hydrocarbon that has been used as a phosphor and in making dyes. Compounds derived from stilbene have been used for medical imaging and as the chemical basis for estrogen-like compounds such as tamoxifen and diethylstilbestrol.

Deal Structure: In September 2002, IDEC licensed this compound from Nippon Shinyaku. Nippon Shinyaku agreed to receive milestones and royalty payments if development is successful, and retains revenue rights in Asia.

Partners: Nippon Shinyaku Co., Ltd.

IDEC-160 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug